Literature DB >> 20447522

Epidermolysis bullosa in Australia and New Zealand.

Dédée F Murrell1.   

Abstract

This article describes the clinical services for EB in Australia and New Zealand. The history and epidemiology of EB in Australia is described. Current treatment and research achievements are described. Copyright 2010 Elsevier Inc. All rights reserved.

Mesh：

Year:  2010        PMID： 20447522     DOI： 10.1016/j.det.2010.02.009

Source DB:  PubMed          Journal:  Dermatol Clin        ISSN： 0733-8635            Impact factor:   3.478


  5 in total

1.  A consensus approach to wound care in epidermolysis bullosa.

Authors:  Elena Pope; Irene Lara-Corrales; Jemima Mellerio; Anna Martinez; Gregory Schultz; Robert Burrell; Laurie Goodman; Patricia Coutts; John Wagner; Upton Allen; Gary Sibbald
Journal:  J Am Acad Dermatol       Date:  2012-03-02       Impact factor: 11.527

2.  Rare case of dysphagia, skin blistering, missing nails in a young boy.

Authors:  Jasbir Makker; Bharat Bajantri; Prospere Remy
Journal:  World J Gastrointest Endosc       Date:  2015-02-16

3.  Access to wound dressings for patients living with epidermolysis bullosa - an Australian perspective.

Authors:  Louise J Stevens
Journal:  Int Wound J       Date:  2012-11-22       Impact factor: 3.315

4.  Assessing the quality of life in the families of patients with epidermolysis bullosa: The mothers as main caregivers.

Authors:  Fatemeh Chogani; Mohammad Mahdi Parvizi; Dedee F Murrell; Farhad Handjani
Journal:  Int J Womens Dermatol       Date:  2021-08-26

Review 5.  Multicentre consensus recommendations for skin care in inherited epidermolysis bullosa.

Authors:  May El Hachem; Giovanna Zambruno; Eva Bourdon-Lanoy; Annalisa Ciasulli; Christiane Buisson; Smail Hadj-Rabia; Andrea Diociaiuti; Carolina F Gouveia; Angela Hernández-Martín; Raul de Lucas Laguna; Mateja Dolenc-Voljč; Gianluca Tadini; Guglielmo Salvatori; Cristiana De Ranieri; Stephanie Leclerc-Mercier; Christine Bodemer
Journal:  Orphanet J Rare Dis       Date:  2014-05-20       Impact factor: 4.123
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.